Walleye Trading
ROIV icon

Walleye Trading’s Roivant Sciences ROIV Stock Holding History

Walleye Trading’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,200
Closed -$338K – 4385
2026
Q1 		$338K Sell
12,200
-72,000
-86% -$1.85M ﹤0.01% 2818
2025
Q4 		$1.83M Buy
84,200
+33,800
+67% +$667K ﹤0.01% 1972
2025
Q3 		$763K Buy
50,400
+11,800
+31% +$146K ﹤0.01% 2451
2025
Q2 		$435K Buy
38,600
+3,400
+10% +$36.9K ﹤0.01% 2738
2025
Q1 		$355K Hold
35,200
– – ﹤0.01% 2747
2024
Q4 		$416K Buy
35,200
+200
+0.6% +$2.37K ﹤0.01% 2747
2024
Q3 		$404K Sell
35,000
-7,200
-17% -$82K ﹤0.01% 2646
2024
Q2 		$446K Buy
+42,200
New +$462K ﹤0.01% 2574

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Walleye Trading's ROIV Position: Q2 2026 in Review

Walleye Trading sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 3,420 shares — an estimated $94.7K sold.

Walleye Trading first reported a position in ROIV in Q4 2023 and held it in 2 quarters. The position peaked at $446K in Q4 2023. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Walleye Trading reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 3,420 Roivant Sciences shares in Q2 2026, an estimated $94.7K.
  • Walleye Trading first reported a position in Roivant Sciences in Q4 2023 and held it in 2 quarters.
  • Walleye Trading's Roivant Sciences position peaked at $446K in Q4 2023.
  • 500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.